SILVERARC CAPITAL MANAGEMENT, LLC
73 holdingsFiling period: 2026-03-31Current AUM: $1.08Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | XNTK | SPDR SERIES TRUST | 825.0K | $105.4M | $139.1M | 12.84% | -- | 2026-03-31 |
| 2 | KALV | KALVISTA PHARMACEUTICALS INC | 2.88M | $57.9M | $57.9M | 5.34% | +449.3K | 2026-03-31 |
| 3 | DNTH | DIANTHUS THERAPEUTICS INC | 654.7K | $54.9M | $70.0M | 6.46% | -95,390 | 2026-03-31 |
| 4 | COGT | COGENT BIOSCIENCES INC | 1.31M | $50.6M | $51.2M | 4.72% | +68.9K | 2026-03-31 |
| 5 | CELC | CELCUITY INC | 357.9K | $40.9M | $30.9M | 2.85% | -17,229 | 2026-03-31 |
| 6 | IMNM | IMMUNOME INC | 1.85M | $40.5M | $42.1M | 3.89% | +724.1K | 2026-03-31 |
| 7 | KOD | KODIAK SCIENCES INC | 991.9K | $37.8M | $41.2M | 3.81% | -31,192 | 2026-03-31 |
| 8 | NUVL | NUVALENT INC | 354.9K | $36.4M | $36.4M | 3.36% | +43.5K | 2026-03-31 |
| 9 | ABVX | ABIVAX SA | 302.5K | $33.7M | $37.8M | 3.49% | -119,663 | 2026-03-31 |
| 10 | GLUE | MONTE ROSA THERAPEUTICS INC | 2.00M | $32.9M | $33.1M | 3.05% | +973.0K | 2026-03-31 |
| 11 | ERAS | ERASCA INC | 1.85M | $30.0M | $33.6M | 3.10% | +534.2K | 2026-03-31 |
| 12 | ASND | ASCENDIS PHARMA A/S | 124.7K | $28.5M | $30.4M | 2.81% | +75.4K | 2026-03-31 |
| 13 | — | UROGEN PHARMA LTD | 1.50M | $27.0M | $27.0M | 2.49% | -235,776 | 2026-03-31 |
| 14 | RYTM | RHYTHM PHARMACEUTICALS INC | 306.0K | $26.6M | $30.4M | 2.80% | +170.1K | 2026-03-31 |
| 15 | PRAX | PRAXIS PRECISION MEDICINES I | 71.6K | $23.1M | $22.0M | 2.03% | -10,913 | 2026-03-31 |
| 16 | ZBIO | ZENAS BIOPHARMA INC | 1.14M | $22.2M | $35.7M | 3.30% | -- | 2026-03-31 |
| 17 | SNDX | SYNDAX PHARMACEUTICALS INC | 889.0K | $20.8M | $16.9M | 1.56% | +246.1K | 2026-03-31 |
| 18 | CNTA | CENTESSA PHARMACEUTICALS PLC | 466.3K | $18.5M | $18.5M | 1.71% | +8.1K | 2026-03-31 |
| 19 | SRRK | SCHOLAR ROCK HLDG CORP | 339.6K | $16.7M | $16.1M | 1.48% | -- | 2026-03-31 |
| 20 | — | ALKERMES PLC | 460.3K | $16.3M | $16.3M | 1.50% | -- | 2026-03-31 |
| 21 | ORIC | ORIC PHARMACEUTICALS INC | 1.10M | $13.9M | $12.2M | 1.12% | -16,594 | 2026-03-31 |
| 22 | IRON | DISC MEDICINE INC | 196.0K | $12.5M | $15.1M | 1.39% | -- | 2026-03-31 |
| 23 | — | HELIX ACQUISITION CORP III | 1.21M | $12.3M | $12.3M | 1.13% | -- | 2026-03-31 |
| 24 | XENE | XENON PHARMACEUTICALS INC | 197.8K | $11.5M | $12.4M | 1.14% | -- | 2026-03-31 |
| 25 | CGON | CG ONCOLOGY INC | 166.3K | $11.3M | $11.8M | 1.09% | -194,809 | 2026-03-31 |
← Scroll →
Page 1 of 3